2024 annual financial data
Xenetic Biosciences 2024 Net margin
Direct answer
Net margin was -158.39%.
Operating income was -4.2M USD and net income was -3.96M USD.
Operating cash flow was -2.82M USD.
Get free Xenetic Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2.5M USD
- Operating income
- -4.2M USD
- Net income
- -3.96M USD
- Operating cash flow
- -2.82M USD